2815. Outcomes of Novel Antimicrobials Compared to Polymyxin B for treatment of infections due Carbapenem-Resistant Enterobacterales Infections

BACKGROUND: Carbapenem-resistant Gram-negative infections remain a serious threat due to their increasing incidence and high mortality rates. Since 2015, various antimicrobials with in vitro activity against carbapenem-resistant Enterobacterales (CRE) have been approved for use. There is limited evi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Tina, Kubin, Christine J, Nelson, Brian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677926/
http://dx.doi.org/10.1093/ofid/ofad500.2426

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677926/
http://dx.doi.org/10.1093/ofid/ofad500.2426

Ejemplares similares